- ¥8bn
- ¥3bn
- ¥13bn
- 90
- 78
- 47
- 88
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.53 | ||
Price to Tang. Book | 0.55 | ||
Price to Free Cashflow | 5.42 | ||
Price to Sales | 0.66 | ||
EV to EBITDA | 2.07 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 4.96% | ||
Return on Equity | 2.49% | ||
Operating Margin | 6.62% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 10,843.96 | 10,830.47 | 11,698.68 | 12,326.54 | 12,585.45 | n/a | n/a | 3.11% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +2.36 | -8.62 | +10.64 | -32.71 | -70.69 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
CREATE MEDIC CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical devices. Its main products include urinary drainage, such as transurethral and nephrostomy; PEG related products; endoscopic products, such as esophagus and stomach; intestinal treatment-devices, such as small intestine and large intestine; anesthesiology products, such as endotracheal tubes and tracheostomy tubes, IVR devices, among others products.
Directors
- Shuzo Yoshino CHM (62)
- Masahiro Sato PRE (53)
- Takao Sekido CEX (60)
- Sumio Ai EXO (57)
- Yozo Akaoka EXO (51)
- Shinichi Endo EXO (49)
- Ichiro Sugimoto EXO (54)
- Hidenori Taniguchi EXO (53)
- Masataka Kasahara OTH (64)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- August 12th, 1974
- Public Since
- July 19th, 2000
- No. of Shareholders
- 6,168
- No. of Employees
- 962
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 8,792,203
- Address
- 2-5-25, Chigasaki-Minami, Tsuzuki-ku, YOKOHAMA-SHI, 224-0037
- Web
- http://www.createmedic.co.jp/
- Phone
- +81 459432611
- Auditors
- KPMG AZSA LLC
Upcoming Events for 5187
Dividend For 5187.T - 20.0000 JPY
Similar to 5187
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
As of Today at 20:06 UTC, shares in Create Medic Co are trading at ¥959. This share price information is delayed by 15 minutes.
Shares in Create Medic Co last closed at ¥959 and the price had moved by +5.27% over the past 365 days. In terms of relative price strength the Create Medic Co share price has underperformed the Nikkei 225 Index by -15.03% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Create Medic Co dividend yield is 3.86% based on the trailing twelve month period.
Last year, Create Medic Co paid a total dividend of ¥37, and it currently has a trailing dividend yield of 3.86%.Looking ahead, shares in Create Medic Co are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01.
Create Medic Co are due to go ex-dividend on 2024-12-27 and the next dividend pay date is 2025-03-01. The historic dividend yield on Create Medic Co shares is currently 3.86%.
To buy shares in Create Medic Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥959, shares in Create Medic Co had a market capitalisation of ¥8bn.
Here are the trading details for Create Medic Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 5187
Based on an overall assessment of its quality, value and momentum Create Medic Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Create Medic Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -5.01%.
As of the last closing price of ¥959, shares in Create Medic Co were trading +0.52% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Create Medic Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥959.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Create Medic Co's management team is headed by:
- Shuzo Yoshino - CHM
- Masahiro Sato - PRE
- Takao Sekido - CEX
- Sumio Ai - EXO
- Yozo Akaoka - EXO
- Shinichi Endo - EXO
- Ichiro Sugimoto - EXO
- Hidenori Taniguchi - EXO
- Masataka Kasahara - OTH